Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapy
- 27 August 2019
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 35 (2) , 197-206
Abstract
To determine (a) whether chronic heart failure with reduced ejection fraction (HFrEF) is associated with increased glycocalyx shedding; (b) whether glycocalyx shedding in HFrEF with left ventricular dyssynchrony is related to inflammation, endothelial dysfunction and/or redox stress and is ameliorated by cardiac resynchronisation therapy. Glycocalyx shedding has been reported to be increased in heart failure and is a marker of increased mortality. Its role in dyssynchronous systolic heart failure and the effects of cardiac resynchronisation therapy (CRT) are largely unknown. Twenty-six patients with dyssynchronous HFrEF were evaluated before and 6 months after CRT insertion. Echocardiographic septal to posterior wall delay (SPWD) assessed intra-ventricular mechanical dyssynchrony, and quality of life, integrity of nitric oxide (NO) signalling, inflammatory and redox-related biomarkers were measured. Glycocalyx shedding was quantitated via plasma levels of the glycocalyx component, syndecan-1. Syndecan-1 levels pre-CRT were inversely correlated with LVEF (r = − 0.45, p = 0.02) and directly with SPWD (r = 0.44, p = 0.02), QOL (r = 0.39, p = 0.04), plasma NT-proBNP (r = 0.43, p = 0.02), and the inflammatory marker, symmetric dimethylarginine (SDMA) (r = 0.54, p = 0.003). On multivariate analysis, syndecan-1 levels were predicted by SPWD and SDMA (β = 0.42, p = 0.009 and β = 0.54, p = 0.001, respectively). No significant correlation was found between syndecan-1 levels and other markers of endothelial dysfunction/inflammatory activation. Following CRT there was no significant change in syndecan-1 levels. In patients with dyssynchronous HFrEF, markers of glycocalyx shedding are associated with the magnitude of mechanical dyssynchrony and elevation of SDMA levels and inversely with LVEF. However, CRT does not reverse this process.Keywords
This publication has 36 references indexed in Scilit:
- Measures of endothelial dysfunction predict response to cardiac resynchronisation therapyOpen Heart, 2016
- Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn’s DiseaseGastroenterology Research and Practice, 2015
- Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapyInternational Journal of Cardiology, 2013
- The Endothelial Glycocalyx as a Barrier to Leukocyte Adhesion and Its Mediation by Extracellular ProteasesAnnals of Biomedical Engineering, 2011
- Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapyJournal of Cardiology, 2011
- Results of the Predictors of Response to CRT (PROSPECT) TrialCirculation, 2008
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Assessment of endothelial function using peripheral waveform analysisJACC, 2002
- Nitrate Resistance In Platelets From Patients With Stable Angina PectorisCirculation, 1999
- Pathohistological Studies on the Conduction System in 8 Cases of Complete Left Bundle Branch BlockJapanese Heart Journal, 1970